Turku Lab
Discover Synexa’s biomarker and bioanalytical capabilities housed in Turku, Finland.
Synexa Turku Lab Overview
Our Turku site brings together advanced biomarker and immunology capabilities to support translational and clinical research. Operating under GCP and GLP certification, with Gyrolab‑certified laboratory capabilities, the team combines strong expertise in immunoassays, molecular analysis and radiopharmaceutical bioanalysis. We are also licensed to handle radioisotopes, enabling safe and compliant analysis of radiolabelled compounds across a range of therapeutic areas.
Working in close partnership with clients, our Turku scientists provide tailored, end‑to‑end support – from study design through to data interpretation – ensuring clear, actionable insights. This collaborative and flexible approach allows us to address complex biological questions and help accelerate programmes from early research through to clinical development.
Turku Lab Services
Immunoassay Services
Radiopharmaceutical Bioanalysis
Specialised radiopharmaceutical bioanalysis solutions enabling accurate measurement of radiolabelled compounds, delivering critical comprehensive insights into biodistribution, pharmacokinetics, and safety profiles.
GyroLab Certified Partner
Our Turku site features a Gyrolab‑certified laboratory, recognising our expertise in automated, high‑sensitivity immunoassay development using Gyros technology. The platform’s low sample consumption, broad dynamic range and strong reproducibility make it particularly well suited to preclinical and clinical studies where precision and limited sample volumes are critical.
Turku Lab FAQs
Where is Synexa's Finland bioanalytical laboratory?
Synexa’s Finland bioanalytical laboratory is located in Turku, Finland. The site supports both regional and international research programmes, providing specialised expertise in biomarker analysis, immunoassays and radiopharmaceutical bioanalysis. The address is:
Synexa Life Sciences Finland OY
Tengströminkatu 8
20380 Turku
Finland
Is the Turku laboratory GLP and GCP accredited?
Yes. Synexa’s Turku laboratory operates under both GLP and GCP accreditation, ensuring studies are conducted in accordance with recognised regulatory and quality standards. The site is also a Gyrolab-certified laboratory, supporting high-sensitivity immunoassay development and analysis.
Which bioanalytical services are available at the Finland laboratory?
The Turku laboratory offers a range of specialist bioanalytical and biomarker services, including:
- Radiopharmaceutical bioanalysis for the measurement and evaluation of radiolabelled compounds.
- Immunoassay services supporting biomarker quantification, immunogenicity assessments and PK studies.
- Gyrolab-based assay development and analysis.
- Molecular and biomarker analysis for translational and clinical research.
- Specialised scientific support from study design through to data interpretation.
Can the Turku laboratory support radiopharmaceutical studies?
Yes. The Turku laboratory is licensed to handle radioisotopes, enabling the safe and compliant analysis of radiolabelled compounds. These capabilities support biodistribution, pharmacokinetic and safety studies across a range of therapeutic programmes.
Can the Turku laboratory support international clinical trials?
Yes. The Turku laboratory supports international clinical and bioanalytical studies through its GLP- and GCP-certified operations, specialised scientific expertise and regulatory-compliant data generation, helping sponsors advance global drug development programmes.
Explore our Other Labs
Manchester, UK
Located just 15 minutes from Manchester Airport, our Manchester laboratory serves as a key hub for clinical bioanalysis, with strong expertise in LC‑MS/MS, PK/TK/PD analysis, and regulated bioanalysis, supporting programmes from early development through to late-phase clinical trials.
Cape Town, South Africa
Synexa’s Cape Town laboratory delivers advanced flow cytometry, cellular immunology, and biomarker solutions, with strong capabilities in translational research, vaccine development and high-dimensional immune profiling to support complex international clinical and bioanalytical studies.
Improving the quality of human health.
Contact Us
Let’s discuss solutions to accelerate your therapeutic pipeline.
